Kuang-Chao Wang

Title: Kuang-Chao Wang: Innovator in Optically Active Compounds

Introduction

Kuang-Chao Wang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of chemistry, particularly in the development of novel optically active compounds. His work has implications for therapeutic applications, showcasing the intersection of innovation and healthcare.

Latest Patents

Wang holds a patent for "Optically active 2,3-dihydroimidazo(1,2-C) quinazoline derivatives." This invention relates to novel optically active 3-substituted methyl-5-methylthio-2,3-dihydroimidazo(1,2-C) quinazoline and 3-substituted methyl-2,3-dihydroimidazo(1,2-C) quinazolin-5(6H)-one. The patent outlines the therapeutic use of these compounds, which can include various substituents such as halogen, hydrogen, methoxy, trifluoromethyl, C1-C4 alkyl, nitro, acetyl, cyano, or hydroxy groups, as well as their pharmaceutically acceptable salts.

Career Highlights

Wang is affiliated with the National Science Council, where he continues to engage in research and development. His work has led to advancements in the field of medicinal chemistry, particularly in the synthesis of compounds that may have therapeutic benefits.

Collaborations

Throughout his career, Wang has collaborated with esteemed colleagues, including Ji-Wang Chern and Alexander Gutcait. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Kuang-Chao Wang's contributions to the field of optically active compounds highlight his role as an influential inventor. His patent work and collaborations reflect a commitment to advancing medicinal chemistry and improving therapeutic options.